Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Colorectal Neoplasms 86Colonic Neoplasms 32Rectal Neoplasms 31Neoplasms 24Pancreatic Neoplasms 22Stomach Neoplasms 20Neoplasm Metastasis 20Esophageal Neoplasms 20Neuroblastoma 12Glioma 11Sarcoma 9Glioblastoma 9Small Cell Lung Carcinoma 8Carcinoma, Non-Small-Cell Lung 8Brain Neoplasms 8Adenocarcinoma Of Esophagus 8Rhabdomyosarcoma 7Lung Neoplasms 7Sarcoma, Ewing 6Gliosarcoma 6Esophageal Squamous Cell Carcinoma 6Medulloblastoma 5Central Nervous System Neoplasms 5Breast Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Intestinal Neoplasms 4Gastrointestinal Neoplasms 4Digestive System Neoplasms 4Digestive System Diseases 4Adenocarcinoma 4

Interventions

Lenalidomide 3Bortezomib 3Dexamethasone 2vandetanib 1umbralisib 1ublituximab 1marizomib 1durvalumab 1carotuximab 1avelumab 1Zoledronic Acid 1Vitamin D 1Transplantation, Autologous 1Tamoxifen 1Standard of Care 1Practice Guidelines as Topic 1Palliative Care 1Oxaliplatin 1Melphalan 1Leucovorin 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Filgrastim 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Disease Progression × Irinotecan × Clear all
NCT00393094 2012-07-13

Bevacizumab and Irinotecan to Treat Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
31 enrolled 12 charts
CNS

Brain Neoplasms, Glioma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡